Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review

Rate of FEV(1) decline in COPD is heterogeneous and the extent to which inhaled corticosteroids (ICS) influence the rate of decline is unclear. The majority of previous reviews have investigated specific ICS and non-ICS inhalers and have consisted of randomised control trials (RCTs), which have spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Whittaker, Hannah R., Jarvis, Debbie, Sheikh, Mohamed R., Kiddle, Steven J., Quint, Jennifer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894275/
https://www.ncbi.nlm.nih.gov/pubmed/31801539
http://dx.doi.org/10.1186/s12931-019-1249-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894275/
https://www.ncbi.nlm.nih.gov/pubmed/31801539
http://dx.doi.org/10.1186/s12931-019-1249-x

Ejemplares similares